Virtu Financial LLC Madrigal Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$120.4 - $237.13 $489,185 - $963,459	4,063 New	4,063 $940,000
Q2 2022 Aug 09, 2022	BUY	$58.04 - $100.2 $189,964 - $327,954	3,273 New	3,273 $234,000
Q4 2018 Jan 16, 2019	SELL	$94.77 - $215.54 $131,351 - $298,738	-1,386 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$207.3 - $300.31 $287,317 - $416,229	1,386 New	1,386 $297,000
Q4 2017 Feb 09, 2018	SELL	$39.35 - $97.37 $245,583 - $607,686	-6,241 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$15.48 - $46.19 $96,610 - $288,271	6,241	6,241 $281,000

338

22.7M

757K

960K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.77B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.